Table 5.
Study | n | Exposure | Units | Outcome | Time of Outcome | Estimate | 95% CI | p-Value |
---|---|---|---|---|---|---|---|---|
Barbone et al. (2019) | 1083 | Hair | ng/g | Bayley-III: Cognitive composite | 18 months | 0.2 | −0.29 to 0.69 | |
Barbone et al. (2019) | 829 | Umbilical cord | ng/g | Bayley-III: Cognitive composite | 18 months | 0.13 | −0.39 to 0.64 | |
Barbone et al. (2019) | 636 | Whole blood | ng/g | Bayley-III: Cognitive composite | 18 months | −0.09 | −0.61 to 0.43 | |
Boucher et al. (2014) | 77 | Umbilical cord | ln μg/L | A-not-B: 2 correct | 11 months | −0.25 | −0.46 to 0.00 | |
Boucher et al. (2014) | 77 | Umbilical cord | ln μg/L | A-not-B: 3 correct | 11 months | −0.22 | −0.45 to 0.03 | |
Boucher et al. (2014) | 73 | Umbilical cord | ln μg/L | Perseverative errors | 11 months | −0.21 | −0.53 to 0.09 | |
Boucher et al. (2014) | 89 | Umbilical cord | ln μg/L | FTII: Novelty preference | 6.5 months | 0.0 | −0.19 to 0.19 | |
Boucher et al. (2014) | 89 | Umbilical cord | ln μg/L | FTIII: Fixation duration | 6.5 months | 0.13 | −0.03 to 0.29 | |
Lin et al. (2013) | 230 | Umbilical cord | Hg ≥ 19.78 μg/L | CDIIT: Cognitive | 24 months | 0.09 | NS | |
Nisevic et al. (2019) | 257 | Umbilical cord | μg/L | Bayley-III: Cognitive composite | 18 months | 0.14 | 0.34 | |
Oken et al. (2008) | 341 | Erythrocyte | ng/g | WRAVMA matching | 36 months | −0.2 | −0.6 to 0.2 | |
Valent et al. (2013) | 505 | Hair | Ln ng/g | Bayley-III: Cognitive composite | 18 months | −0.002 | 0.99 | |
Valent et al. (2013) | 378 | Umbilical cord | Ln ng/g | Bayley-III: Cognitive composite | 18 months | 0.05 | 0.92 | |
Xu et al. (2016) | 270 | Umbilical cord | μg/L | NNNS: Attention | 5 weeks | 0.12 | 0.23 | |
Xu et al. (2016) | 344 | Whole blood | μg/L | NNNS: Attention | 5 weeks | 0.15 | 0.22 |